Temporary vs.Long Term Hemodialysis Catheter on Central Vein Stenosis

NCT ID: NCT04399564

Last Updated: 2021-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-25

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vascular access (VA) is the most important for carrying out hemodialysis, yet it may bring in complications and leads to hemodialysis quality decline. This study aimed to explore the impact of vascular access types, including temporary vs.long term hemodialysis catheter on central vein stenosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is unknown whether central vein stenosis occurs after temporary or long term hemodialysis catheter in long-term hemodialysis patients. this study will aim to explore this question. Study design is randomized, controlled trial. One arm is temporary catheters in the internal jugular vein, and another arm is tunneled cuffed hemodialysis cather. 2\*2 is randomly distributed.

The main outcome: central vein stenosis diagnosed by venography. The secondary outcome: the time of infection, and catheter patency. Study period: one year

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stenosis of Arteriovenous Dialysis Fistula

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized controlled trial
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

temporary hemodialysis catheters

one arm-temporary hemodialysis catheter

Group Type ACTIVE_COMPARATOR

temporary hemodialysis catheters

Intervention Type DEVICE

Vascular access using temporary vs.long-term hemodialysis catheters

long-term hemodialysis catheters

another arm-long term hemodialysis catheter

Group Type EXPERIMENTAL

long-term hemodialysis catheters

Intervention Type DEVICE

long-term hemodialysis catheters

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

temporary hemodialysis catheters

Vascular access using temporary vs.long-term hemodialysis catheters

Intervention Type DEVICE

long-term hemodialysis catheters

long-term hemodialysis catheters

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* need to receive long-term hemodialysis no arteriovenous shunts or immature arteriovenous shunts

Exclusion Criteria

* Uremia with heart failure or lung function failure
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Pudong Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hui Min Jin, MD

Role: PRINCIPAL_INVESTIGATOR

Shanghai Pudong Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hui Min Jin, MD

Role: CONTACT

13917232915

Xiu Hong Yang, MD

Role: CONTACT

18317070897

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ShanghaiPudongH3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.